Atai Life Sciences N.V. (ATAI)

USD 1.18

(-10.61%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue 314 Thousand 233 Thousand 20.37 Million - -
Cost of Revenue 319 Thousand 168 Thousand 47 Thousand 24 Thousand 6000.00
Gross Profit -5000.00 65 Thousand 20.32 Million -24 Thousand -6000.00
Operating Expenses 125.78 Million 144.66 Million 140.7 Million 92.14 Million 8.17 Million
Selling, General and Administrative Expenses 63.58 Million 70.35 Million 92.74 Million 80.73 Million 5.09 Million
Research and Development Expenses 62.2 Million 74.31 Million 47.95 Million 11.4 Million 3.08 Million
Other Expenses - 9.6 Million -796 Thousand -16.09 Million 425 Thousand
Cost and Expenses 125.78 Million 144.66 Million 140.7 Million 92.14 Million 8.17 Million
Operating Income -125.47 Million -144.78 Million -135.8 Million -104.16 Million 1.57 Million
Interest Expense 2.65 Million 1.91 Million - - -
Income Tax Expense 1.01 Million 6.22 Million -3.98 Million 305 Thousand 2000.00
Earnings before Tax -39.28 Million -135.18 Million -136.6 Million -101.81 Million -17.47 Million
Net Income -40.22 Million -141.41 Million -132.61 Million -102.11 Million -17.47 Million
Earnings Per Share Basic -0.25 -0.91 -0.83 -17.57 -3.23
Earnings Per Share Diluted -0.25 -0.91 -0.83 -17.57 -3.23
Weighted Average Shares Outstanding 158.83 Million 155.71 Million 160.67 Million 5.81 Million 5.41 Million
Weighted Average Shares Outstanding (Diluted) 158.83 Million 155.71 Million 160.67 Million 5.81 Million 5.41 Million
Gross Margin -0.02 0.28 1.00 - -
EBIT Margin -115.64 -618.34 -5.15 - -
Profit Margin -128.10 -606.91 -6.51 - -
EBITDA -36.31 Million -135.01 Million -120.27 Million -92.11 Million -17.46 Million
Earnings Before Tax Margin -399.59 -621.40 -6.66 - -

Income Statement Charts